Documentos relacionados

1. Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial.
2. Ultrasensitive electrochemical detection of furazolidone in biological samples using 1D-2D BiVO₄@MoS₂ hierarchical nano-heterojunction composites armed electrodes.
3. Enhancing catalytic activity through the construction of praseodymium tungstate decorated on hierarchical three-dimensional porous biocarbon for determination of furazolidone in aquatic samples.
4. Descripción de la resistencia de Helicobacter pylori a seis antibióticos de uso frecuente en Colombia
5. Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial.
6. Rapid chemical reduction synthesis of copper nanoclusters with blue fluorescence for highly sensitive detection of furazolidone.
7. Erradicación de la infección por helicobacter pylori utilizando tetraciclina, furazolidona y bismuto en pacientes dispépticos con y sin úlcera péptica
8. [Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province].
9. [Jinghuaweikang capsules combined with furazolidone-based triple or quadruple therapy as the rescue treatment for Helicobacter pylori infection: a multicenter randomized controlled clinical trial].
10. Clarithromycin versus furazolidone for naïve Helicobacter pylori infected patients in a high clarithromycin resistance area.